nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—CYP3A5—Beclomethasone—psoriasis	0.08	0.113	CbGbCtD
Buspirone—CYP2D6—Hydroxyurea—psoriasis	0.0372	0.0527	CbGbCtD
Buspirone—CYP3A7—Hydrocortisone—psoriasis	0.0341	0.0483	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0341	0.0483	CbGbCtD
Buspirone—CYP3A7—Cyclosporine—psoriasis	0.0322	0.0456	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0322	0.0456	CbGbCtD
Buspirone—CYP3A5—Mycophenolate mofetil—psoriasis	0.0318	0.0451	CbGbCtD
Buspirone—CYP3A4—Calcitriol—psoriasis	0.0278	0.0394	CbGbCtD
Buspirone—CYP3A5—Hydrocortisone—psoriasis	0.0255	0.0362	CbGbCtD
Buspirone—CYP3A5—Cyclosporine—psoriasis	0.0241	0.0342	CbGbCtD
Buspirone—CYP2D6—Cholecalciferol—psoriasis	0.0225	0.0319	CbGbCtD
Buspirone—CYP3A4—Methoxsalen—psoriasis	0.0216	0.0306	CbGbCtD
Buspirone—CYP3A7—Dexamethasone—psoriasis	0.0212	0.03	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0212	0.03	CbGbCtD
Buspirone—ABCB1—Mycophenolate mofetil—psoriasis	0.0207	0.0294	CbGbCtD
Buspirone—ABCB1—Betamethasone—psoriasis	0.0178	0.0252	CbGbCtD
Buspirone—ABCB1—Prednisolone—psoriasis	0.0175	0.0249	CbGbCtD
Buspirone—ABCB1—Hydrocortisone—psoriasis	0.0166	0.0236	CbGbCtD
Buspirone—ABCB1—Prednisone—psoriasis	0.0166	0.0235	CbGbCtD
Buspirone—CYP3A5—Dexamethasone—psoriasis	0.0159	0.0225	CbGbCtD
Buspirone—ABCB1—Cyclosporine—psoriasis	0.0157	0.0223	CbGbCtD
Buspirone—CYP2D6—Cyclosporine—psoriasis	0.0148	0.021	CbGbCtD
Buspirone—CYP3A4—Cholecalciferol—psoriasis	0.0143	0.0203	CbGbCtD
Buspirone—CYP3A4—Mycophenolate mofetil—psoriasis	0.0124	0.0176	CbGbCtD
Buspirone—CYP3A4—Triamcinolone—psoriasis	0.0124	0.0176	CbGbCtD
Buspirone—CYP3A4—Betamethasone—psoriasis	0.0106	0.0151	CbGbCtD
Buspirone—CYP3A4—Prednisolone—psoriasis	0.0105	0.0149	CbGbCtD
Buspirone—ABCB1—Dexamethasone—psoriasis	0.0103	0.0147	CbGbCtD
Buspirone—CYP3A4—Hydrocortisone—psoriasis	0.00996	0.0141	CbGbCtD
Buspirone—CYP3A4—Prednisone—psoriasis	0.00992	0.0141	CbGbCtD
Buspirone—CYP2D6—Dexamethasone—psoriasis	0.00974	0.0138	CbGbCtD
Buspirone—CYP3A4—Cyclosporine—psoriasis	0.00941	0.0133	CbGbCtD
Buspirone—ABCB1—Methotrexate—psoriasis	0.00831	0.0118	CbGbCtD
Buspirone—CYP3A4—Dexamethasone—psoriasis	0.00619	0.00879	CbGbCtD
Buspirone—Diarrhoea—Mycophenolic acid—psoriasis	0.000133	0.000472	CcSEcCtD
Buspirone—Conjunctivitis—Methotrexate—psoriasis	0.000132	0.00047	CcSEcCtD
Buspirone—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000132	0.00047	CcSEcCtD
Buspirone—Malaise—Dexamethasone—psoriasis	0.000132	0.000469	CcSEcCtD
Buspirone—Malaise—Betamethasone—psoriasis	0.000132	0.000469	CcSEcCtD
Buspirone—Oedema—Triamcinolone—psoriasis	0.000132	0.000467	CcSEcCtD
Buspirone—Vertigo—Dexamethasone—psoriasis	0.000131	0.000467	CcSEcCtD
Buspirone—Vertigo—Betamethasone—psoriasis	0.000131	0.000467	CcSEcCtD
Buspirone—Syncope—Dexamethasone—psoriasis	0.000131	0.000466	CcSEcCtD
Buspirone—Syncope—Betamethasone—psoriasis	0.000131	0.000466	CcSEcCtD
Buspirone—Constipation—Mycophenolate mofetil—psoriasis	0.000131	0.000466	CcSEcCtD
Buspirone—Pain—Mycophenolate mofetil—psoriasis	0.000131	0.000466	CcSEcCtD
Buspirone—Sweating—Methotrexate—psoriasis	0.000131	0.000464	CcSEcCtD
Buspirone—Hypotension—Hydrocortisone—psoriasis	0.000131	0.000464	CcSEcCtD
Buspirone—Feeling abnormal—Cyclosporine—psoriasis	0.00013	0.00046	CcSEcCtD
Buspirone—Shock—Triamcinolone—psoriasis	0.000129	0.00046	CcSEcCtD
Buspirone—Insomnia—Prednisolone—psoriasis	0.000129	0.00046	CcSEcCtD
Buspirone—Alopecia—Prednisone—psoriasis	0.000129	0.000459	CcSEcCtD
Buspirone—Loss of consciousness—Betamethasone—psoriasis	0.000129	0.000457	CcSEcCtD
Buspirone—Loss of consciousness—Dexamethasone—psoriasis	0.000129	0.000457	CcSEcCtD
Buspirone—Dizziness—Mycophenolic acid—psoriasis	0.000128	0.000457	CcSEcCtD
Buspirone—Epistaxis—Methotrexate—psoriasis	0.000128	0.000457	CcSEcCtD
Buspirone—Paraesthesia—Prednisolone—psoriasis	0.000128	0.000456	CcSEcCtD
Buspirone—Tachycardia—Triamcinolone—psoriasis	0.000128	0.000456	CcSEcCtD
Buspirone—Erythema—Prednisone—psoriasis	0.000127	0.000453	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000127	0.000452	CcSEcCtD
Buspirone—Hyperhidrosis—Triamcinolone—psoriasis	0.000127	0.000452	CcSEcCtD
Buspirone—Convulsion—Dexamethasone—psoriasis	0.000127	0.00045	CcSEcCtD
Buspirone—Convulsion—Betamethasone—psoriasis	0.000127	0.00045	CcSEcCtD
Buspirone—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000126	0.000449	CcSEcCtD
Buspirone—Insomnia—Hydrocortisone—psoriasis	0.000126	0.000449	CcSEcCtD
Buspirone—Hypertension—Betamethasone—psoriasis	0.000126	0.000449	CcSEcCtD
Buspirone—Hypertension—Dexamethasone—psoriasis	0.000126	0.000449	CcSEcCtD
Buspirone—Paraesthesia—Hydrocortisone—psoriasis	0.000125	0.000446	CcSEcCtD
Buspirone—Urticaria—Cyclosporine—psoriasis	0.000125	0.000444	CcSEcCtD
Buspirone—Myalgia—Betamethasone—psoriasis	0.000124	0.000442	CcSEcCtD
Buspirone—Myalgia—Dexamethasone—psoriasis	0.000124	0.000442	CcSEcCtD
Buspirone—Body temperature increased—Cyclosporine—psoriasis	0.000124	0.000442	CcSEcCtD
Buspirone—Vomiting—Mycophenolic acid—psoriasis	0.000124	0.000439	CcSEcCtD
Buspirone—Discomfort—Dexamethasone—psoriasis	0.000123	0.000437	CcSEcCtD
Buspirone—Discomfort—Betamethasone—psoriasis	0.000123	0.000437	CcSEcCtD
Buspirone—Dyspepsia—Hydrocortisone—psoriasis	0.000123	0.000437	CcSEcCtD
Buspirone—Haemoglobin—Methotrexate—psoriasis	0.000123	0.000437	CcSEcCtD
Buspirone—Rash—Mycophenolic acid—psoriasis	0.000122	0.000435	CcSEcCtD
Buspirone—Dermatitis—Mycophenolic acid—psoriasis	0.000122	0.000435	CcSEcCtD
Buspirone—Pain—Prednisolone—psoriasis	0.000122	0.000435	CcSEcCtD
Buspirone—Haemorrhage—Methotrexate—psoriasis	0.000122	0.000434	CcSEcCtD
Buspirone—Urticaria—Mycophenolate mofetil—psoriasis	0.000122	0.000433	CcSEcCtD
Buspirone—Headache—Mycophenolic acid—psoriasis	0.000122	0.000433	CcSEcCtD
Buspirone—Decreased appetite—Hydrocortisone—psoriasis	0.000121	0.000432	CcSEcCtD
Buspirone—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000121	0.000431	CcSEcCtD
Buspirone—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000121	0.000429	CcSEcCtD
Buspirone—Fatigue—Hydrocortisone—psoriasis	0.00012	0.000428	CcSEcCtD
Buspirone—Vision blurred—Prednisone—psoriasis	0.00012	0.000427	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.00012	0.000426	CcSEcCtD
Buspirone—Pain—Hydrocortisone—psoriasis	0.000119	0.000425	CcSEcCtD
Buspirone—Oedema—Dexamethasone—psoriasis	0.000119	0.000424	CcSEcCtD
Buspirone—Oedema—Betamethasone—psoriasis	0.000119	0.000424	CcSEcCtD
Buspirone—Insomnia—Triamcinolone—psoriasis	0.000119	0.000423	CcSEcCtD
Buspirone—Ill-defined disorder—Prednisone—psoriasis	0.000118	0.00042	CcSEcCtD
Buspirone—Paraesthesia—Triamcinolone—psoriasis	0.000118	0.00042	CcSEcCtD
Buspirone—Feeling abnormal—Prednisolone—psoriasis	0.000118	0.000419	CcSEcCtD
Buspirone—Shock—Dexamethasone—psoriasis	0.000117	0.000417	CcSEcCtD
Buspirone—Shock—Betamethasone—psoriasis	0.000117	0.000417	CcSEcCtD
Buspirone—Dyspnoea—Triamcinolone—psoriasis	0.000117	0.000417	CcSEcCtD
Buspirone—Agitation—Prednisone—psoriasis	0.000117	0.000416	CcSEcCtD
Buspirone—Thrombocytopenia—Betamethasone—psoriasis	0.000117	0.000415	CcSEcCtD
Buspirone—Thrombocytopenia—Dexamethasone—psoriasis	0.000117	0.000415	CcSEcCtD
Buspirone—Tachycardia—Dexamethasone—psoriasis	0.000116	0.000414	CcSEcCtD
Buspirone—Tachycardia—Betamethasone—psoriasis	0.000116	0.000414	CcSEcCtD
Buspirone—Angioedema—Prednisone—psoriasis	0.000116	0.000414	CcSEcCtD
Buspirone—Hypersensitivity—Cyclosporine—psoriasis	0.000116	0.000412	CcSEcCtD
Buspirone—Dyspepsia—Triamcinolone—psoriasis	0.000116	0.000411	CcSEcCtD
Buspirone—Nausea—Mycophenolic acid—psoriasis	0.000115	0.00041	CcSEcCtD
Buspirone—Hyperhidrosis—Dexamethasone—psoriasis	0.000115	0.00041	CcSEcCtD
Buspirone—Hyperhidrosis—Betamethasone—psoriasis	0.000115	0.00041	CcSEcCtD
Buspirone—Feeling abnormal—Hydrocortisone—psoriasis	0.000115	0.000409	CcSEcCtD
Buspirone—Malaise—Prednisone—psoriasis	0.000115	0.000408	CcSEcCtD
Buspirone—Vertigo—Prednisone—psoriasis	0.000114	0.000407	CcSEcCtD
Buspirone—Syncope—Prednisone—psoriasis	0.000114	0.000406	CcSEcCtD
Buspirone—Tinnitus—Methotrexate—psoriasis	0.000114	0.000405	CcSEcCtD
Buspirone—Anorexia—Dexamethasone—psoriasis	0.000114	0.000404	CcSEcCtD
Buspirone—Anorexia—Betamethasone—psoriasis	0.000114	0.000404	CcSEcCtD
Buspirone—Urticaria—Prednisolone—psoriasis	0.000114	0.000404	CcSEcCtD
Buspirone—Fatigue—Triamcinolone—psoriasis	0.000113	0.000403	CcSEcCtD
Buspirone—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000113	0.000401	CcSEcCtD
Buspirone—Asthenia—Cyclosporine—psoriasis	0.000113	0.000401	CcSEcCtD
Buspirone—Pain—Triamcinolone—psoriasis	0.000112	0.0004	CcSEcCtD
Buspirone—Loss of consciousness—Prednisone—psoriasis	0.000112	0.000398	CcSEcCtD
Buspirone—Hypotension—Betamethasone—psoriasis	0.000112	0.000396	CcSEcCtD
Buspirone—Hypotension—Dexamethasone—psoriasis	0.000112	0.000396	CcSEcCtD
Buspirone—Pruritus—Cyclosporine—psoriasis	0.000111	0.000395	CcSEcCtD
Buspirone—Urticaria—Hydrocortisone—psoriasis	0.000111	0.000394	CcSEcCtD
Buspirone—Body temperature increased—Hydrocortisone—psoriasis	0.00011	0.000392	CcSEcCtD
Buspirone—Convulsion—Prednisone—psoriasis	0.00011	0.000392	CcSEcCtD
Buspirone—Asthenia—Mycophenolate mofetil—psoriasis	0.00011	0.000391	CcSEcCtD
Buspirone—Hypertension—Prednisone—psoriasis	0.00011	0.000391	CcSEcCtD
Buspirone—Chills—Methotrexate—psoriasis	0.00011	0.00039	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000109	0.000386	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000109	0.000386	CcSEcCtD
Buspirone—Pruritus—Mycophenolate mofetil—psoriasis	0.000108	0.000386	CcSEcCtD
Buspirone—Myalgia—Prednisone—psoriasis	0.000108	0.000385	CcSEcCtD
Buspirone—Arthralgia—Prednisone—psoriasis	0.000108	0.000385	CcSEcCtD
Buspirone—Feeling abnormal—Triamcinolone—psoriasis	0.000108	0.000385	CcSEcCtD
Buspirone—Alopecia—Methotrexate—psoriasis	0.000108	0.000384	CcSEcCtD
Buspirone—Insomnia—Dexamethasone—psoriasis	0.000108	0.000384	CcSEcCtD
Buspirone—Insomnia—Betamethasone—psoriasis	0.000108	0.000384	CcSEcCtD
Buspirone—Diarrhoea—Cyclosporine—psoriasis	0.000108	0.000382	CcSEcCtD
Buspirone—Paraesthesia—Dexamethasone—psoriasis	0.000107	0.000381	CcSEcCtD
Buspirone—Paraesthesia—Betamethasone—psoriasis	0.000107	0.000381	CcSEcCtD
Buspirone—Discomfort—Prednisone—psoriasis	0.000107	0.000381	CcSEcCtD
Buspirone—Erythema—Methotrexate—psoriasis	0.000106	0.000378	CcSEcCtD
Buspirone—Hypersensitivity—Prednisolone—psoriasis	0.000105	0.000374	CcSEcCtD
Buspirone—Dyspepsia—Dexamethasone—psoriasis	0.000105	0.000373	CcSEcCtD
Buspirone—Dyspepsia—Betamethasone—psoriasis	0.000105	0.000373	CcSEcCtD
Buspirone—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000105	0.000373	CcSEcCtD
Buspirone—Urticaria—Triamcinolone—psoriasis	0.000104	0.000371	CcSEcCtD
Buspirone—Dysgeusia—Methotrexate—psoriasis	0.000104	0.00037	CcSEcCtD
Buspirone—Body temperature increased—Triamcinolone—psoriasis	0.000104	0.00037	CcSEcCtD
Buspirone—Dizziness—Cyclosporine—psoriasis	0.000104	0.000369	CcSEcCtD
Buspirone—Oedema—Prednisone—psoriasis	0.000104	0.000369	CcSEcCtD
Buspirone—Decreased appetite—Dexamethasone—psoriasis	0.000104	0.000369	CcSEcCtD
Buspirone—Decreased appetite—Betamethasone—psoriasis	0.000104	0.000369	CcSEcCtD
Buspirone—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000103	0.000366	CcSEcCtD
Buspirone—Gastrointestinal disorder—Betamethasone—psoriasis	0.000103	0.000366	CcSEcCtD
Buspirone—Hypersensitivity—Hydrocortisone—psoriasis	0.000103	0.000366	CcSEcCtD
Buspirone—Fatigue—Betamethasone—psoriasis	0.000103	0.000366	CcSEcCtD
Buspirone—Fatigue—Dexamethasone—psoriasis	0.000103	0.000366	CcSEcCtD
Buspirone—Shock—Prednisone—psoriasis	0.000102	0.000363	CcSEcCtD
Buspirone—Pain—Betamethasone—psoriasis	0.000102	0.000363	CcSEcCtD
Buspirone—Pain—Dexamethasone—psoriasis	0.000102	0.000363	CcSEcCtD
Buspirone—Tachycardia—Prednisone—psoriasis	0.000101	0.00036	CcSEcCtD
Buspirone—Dizziness—Mycophenolate mofetil—psoriasis	0.000101	0.00036	CcSEcCtD
Buspirone—Hyperhidrosis—Prednisone—psoriasis	0.0001	0.000357	CcSEcCtD
Buspirone—Vision blurred—Methotrexate—psoriasis	0.0001	0.000356	CcSEcCtD
Buspirone—Asthenia—Hydrocortisone—psoriasis	0.0001	0.000356	CcSEcCtD
Buspirone—Vomiting—Cyclosporine—psoriasis	9.99e-05	0.000355	CcSEcCtD
Buspirone—Rash—Cyclosporine—psoriasis	9.91e-05	0.000352	CcSEcCtD
Buspirone—Anorexia—Prednisone—psoriasis	9.91e-05	0.000352	CcSEcCtD
Buspirone—Dermatitis—Cyclosporine—psoriasis	9.9e-05	0.000352	CcSEcCtD
Buspirone—Pruritus—Hydrocortisone—psoriasis	9.88e-05	0.000351	CcSEcCtD
Buspirone—Ill-defined disorder—Methotrexate—psoriasis	9.87e-05	0.000351	CcSEcCtD
Buspirone—Headache—Cyclosporine—psoriasis	9.85e-05	0.00035	CcSEcCtD
Buspirone—Feeling abnormal—Dexamethasone—psoriasis	9.83e-05	0.00035	CcSEcCtD
Buspirone—Feeling abnormal—Betamethasone—psoriasis	9.83e-05	0.00035	CcSEcCtD
Buspirone—Vomiting—Mycophenolate mofetil—psoriasis	9.75e-05	0.000346	CcSEcCtD
Buspirone—Hypersensitivity—Triamcinolone—psoriasis	9.69e-05	0.000344	CcSEcCtD
Buspirone—Rash—Mycophenolate mofetil—psoriasis	9.67e-05	0.000344	CcSEcCtD
Buspirone—Dermatitis—Mycophenolate mofetil—psoriasis	9.66e-05	0.000343	CcSEcCtD
Buspirone—Headache—Mycophenolate mofetil—psoriasis	9.6e-05	0.000341	CcSEcCtD
Buspirone—Malaise—Methotrexate—psoriasis	9.6e-05	0.000341	CcSEcCtD
Buspirone—Vertigo—Methotrexate—psoriasis	9.56e-05	0.00034	CcSEcCtD
Buspirone—Diarrhoea—Hydrocortisone—psoriasis	9.56e-05	0.00034	CcSEcCtD
Buspirone—Leukopenia—Methotrexate—psoriasis	9.53e-05	0.000339	CcSEcCtD
Buspirone—Urticaria—Dexamethasone—psoriasis	9.48e-05	0.000337	CcSEcCtD
Buspirone—Urticaria—Betamethasone—psoriasis	9.48e-05	0.000337	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Prednisone—psoriasis	9.47e-05	0.000337	CcSEcCtD
Buspirone—Dizziness—Prednisolone—psoriasis	9.46e-05	0.000336	CcSEcCtD
Buspirone—Asthenia—Triamcinolone—psoriasis	9.44e-05	0.000335	CcSEcCtD
Buspirone—Body temperature increased—Dexamethasone—psoriasis	9.43e-05	0.000335	CcSEcCtD
Buspirone—Body temperature increased—Betamethasone—psoriasis	9.43e-05	0.000335	CcSEcCtD
Buspirone—Insomnia—Prednisone—psoriasis	9.4e-05	0.000334	CcSEcCtD
Buspirone—Nausea—Cyclosporine—psoriasis	9.34e-05	0.000332	CcSEcCtD
Buspirone—Paraesthesia—Prednisone—psoriasis	9.33e-05	0.000332	CcSEcCtD
Buspirone—Pruritus—Triamcinolone—psoriasis	9.31e-05	0.000331	CcSEcCtD
Buspirone—Dizziness—Hydrocortisone—psoriasis	9.24e-05	0.000328	CcSEcCtD
Buspirone—Convulsion—Methotrexate—psoriasis	9.22e-05	0.000328	CcSEcCtD
Buspirone—Dyspepsia—Prednisone—psoriasis	9.15e-05	0.000325	CcSEcCtD
Buspirone—Nausea—Mycophenolate mofetil—psoriasis	9.11e-05	0.000324	CcSEcCtD
Buspirone—Chest pain—Methotrexate—psoriasis	9.06e-05	0.000322	CcSEcCtD
Buspirone—Myalgia—Methotrexate—psoriasis	9.06e-05	0.000322	CcSEcCtD
Buspirone—Arthralgia—Methotrexate—psoriasis	9.06e-05	0.000322	CcSEcCtD
Buspirone—Decreased appetite—Prednisone—psoriasis	9.03e-05	0.000321	CcSEcCtD
Buspirone—Rash—Prednisolone—psoriasis	9.02e-05	0.00032	CcSEcCtD
Buspirone—Dermatitis—Prednisolone—psoriasis	9.01e-05	0.00032	CcSEcCtD
Buspirone—Fatigue—Prednisone—psoriasis	8.96e-05	0.000318	CcSEcCtD
Buspirone—Headache—Prednisolone—psoriasis	8.96e-05	0.000318	CcSEcCtD
Buspirone—Discomfort—Methotrexate—psoriasis	8.95e-05	0.000318	CcSEcCtD
Buspirone—DRD2—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	8.9e-05	0.00655	CbGpPWpGaD
Buspirone—Constipation—Prednisone—psoriasis	8.89e-05	0.000316	CcSEcCtD
Buspirone—Vomiting—Hydrocortisone—psoriasis	8.88e-05	0.000316	CcSEcCtD
Buspirone—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	8.86e-05	0.00652	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—HCAR2—psoriasis	8.86e-05	0.00652	CbGpPWpGaD
Buspirone—Rash—Hydrocortisone—psoriasis	8.81e-05	0.000313	CcSEcCtD
Buspirone—Dermatitis—Hydrocortisone—psoriasis	8.8e-05	0.000313	CcSEcCtD
Buspirone—Confusional state—Methotrexate—psoriasis	8.76e-05	0.000311	CcSEcCtD
Buspirone—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	8.76e-05	0.00645	CbGpPWpGaD
Buspirone—Headache—Hydrocortisone—psoriasis	8.75e-05	0.000311	CcSEcCtD
Buspirone—Dizziness—Triamcinolone—psoriasis	8.7e-05	0.000309	CcSEcCtD
Buspirone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.58e-05	0.00632	CbGpPWpGaD
Buspirone—Feeling abnormal—Prednisone—psoriasis	8.56e-05	0.000304	CcSEcCtD
Buspirone—Asthenia—Betamethasone—psoriasis	8.56e-05	0.000304	CcSEcCtD
Buspirone—Asthenia—Dexamethasone—psoriasis	8.56e-05	0.000304	CcSEcCtD
Buspirone—Thrombocytopenia—Methotrexate—psoriasis	8.5e-05	0.000302	CcSEcCtD
Buspirone—Nausea—Prednisolone—psoriasis	8.5e-05	0.000302	CcSEcCtD
Buspirone—Pruritus—Betamethasone—psoriasis	8.44e-05	0.0003	CcSEcCtD
Buspirone—Pruritus—Dexamethasone—psoriasis	8.44e-05	0.0003	CcSEcCtD
Buspirone—Hyperhidrosis—Methotrexate—psoriasis	8.4e-05	0.000298	CcSEcCtD
Buspirone—Vomiting—Triamcinolone—psoriasis	8.36e-05	0.000297	CcSEcCtD
Buspirone—Nausea—Hydrocortisone—psoriasis	8.3e-05	0.000295	CcSEcCtD
Buspirone—Rash—Triamcinolone—psoriasis	8.29e-05	0.000295	CcSEcCtD
Buspirone—Dermatitis—Triamcinolone—psoriasis	8.28e-05	0.000294	CcSEcCtD
Buspirone—Anorexia—Methotrexate—psoriasis	8.28e-05	0.000294	CcSEcCtD
Buspirone—Urticaria—Prednisone—psoriasis	8.26e-05	0.000293	CcSEcCtD
Buspirone—Headache—Triamcinolone—psoriasis	8.24e-05	0.000293	CcSEcCtD
Buspirone—Body temperature increased—Prednisone—psoriasis	8.22e-05	0.000292	CcSEcCtD
Buspirone—Diarrhoea—Dexamethasone—psoriasis	8.17e-05	0.00029	CcSEcCtD
Buspirone—Diarrhoea—Betamethasone—psoriasis	8.17e-05	0.00029	CcSEcCtD
Buspirone—Hypotension—Methotrexate—psoriasis	8.12e-05	0.000288	CcSEcCtD
Buspirone—HTR2A—SIDS Susceptibility Pathways—RUNX3—psoriasis	7.94e-05	0.00584	CbGpPWpGaD
Buspirone—Musculoskeletal discomfort—Methotrexate—psoriasis	7.91e-05	0.000281	CcSEcCtD
Buspirone—Dizziness—Betamethasone—psoriasis	7.89e-05	0.00028	CcSEcCtD
Buspirone—Dizziness—Dexamethasone—psoriasis	7.89e-05	0.00028	CcSEcCtD
Buspirone—Insomnia—Methotrexate—psoriasis	7.86e-05	0.000279	CcSEcCtD
Buspirone—Nausea—Triamcinolone—psoriasis	7.81e-05	0.000278	CcSEcCtD
Buspirone—Paraesthesia—Methotrexate—psoriasis	7.8e-05	0.000277	CcSEcCtD
Buspirone—Dyspnoea—Methotrexate—psoriasis	7.74e-05	0.000275	CcSEcCtD
Buspirone—Somnolence—Methotrexate—psoriasis	7.72e-05	0.000274	CcSEcCtD
Buspirone—HTR1A—GPCR ligand binding—HCAR2—psoriasis	7.72e-05	0.00568	CbGpPWpGaD
Buspirone—Hypersensitivity—Prednisone—psoriasis	7.66e-05	0.000272	CcSEcCtD
Buspirone—Dyspepsia—Methotrexate—psoriasis	7.65e-05	0.000272	CcSEcCtD
Buspirone—DRD3—G alpha (i) signalling events—CCL20—psoriasis	7.6e-05	0.00559	CbGpPWpGaD
Buspirone—Vomiting—Betamethasone—psoriasis	7.59e-05	0.00027	CcSEcCtD
Buspirone—Vomiting—Dexamethasone—psoriasis	7.59e-05	0.00027	CcSEcCtD
Buspirone—CYP2D6—Biological oxidations—CYP2S1—psoriasis	7.58e-05	0.00558	CbGpPWpGaD
Buspirone—Decreased appetite—Methotrexate—psoriasis	7.55e-05	0.000268	CcSEcCtD
Buspirone—Rash—Betamethasone—psoriasis	7.52e-05	0.000267	CcSEcCtD
Buspirone—Rash—Dexamethasone—psoriasis	7.52e-05	0.000267	CcSEcCtD
Buspirone—Dermatitis—Dexamethasone—psoriasis	7.52e-05	0.000267	CcSEcCtD
Buspirone—Dermatitis—Betamethasone—psoriasis	7.52e-05	0.000267	CcSEcCtD
Buspirone—Gastrointestinal disorder—Methotrexate—psoriasis	7.5e-05	0.000267	CcSEcCtD
Buspirone—Fatigue—Methotrexate—psoriasis	7.49e-05	0.000266	CcSEcCtD
Buspirone—Headache—Betamethasone—psoriasis	7.48e-05	0.000266	CcSEcCtD
Buspirone—Headache—Dexamethasone—psoriasis	7.48e-05	0.000266	CcSEcCtD
Buspirone—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	7.47e-05	0.0055	CbGpPWpGaD
Buspirone—Asthenia—Prednisone—psoriasis	7.46e-05	0.000265	CcSEcCtD
Buspirone—Pain—Methotrexate—psoriasis	7.43e-05	0.000264	CcSEcCtD
Buspirone—Pruritus—Prednisone—psoriasis	7.35e-05	0.000261	CcSEcCtD
Buspirone—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	7.35e-05	0.00541	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—IL13—psoriasis	7.25e-05	0.00534	CbGpPWpGaD
Buspirone—Feeling abnormal—Methotrexate—psoriasis	7.16e-05	0.000254	CcSEcCtD
Buspirone—Diarrhoea—Prednisone—psoriasis	7.11e-05	0.000253	CcSEcCtD
Buspirone—Nausea—Betamethasone—psoriasis	7.09e-05	0.000252	CcSEcCtD
Buspirone—Nausea—Dexamethasone—psoriasis	7.09e-05	0.000252	CcSEcCtD
Buspirone—Urticaria—Methotrexate—psoriasis	6.9e-05	0.000245	CcSEcCtD
Buspirone—Dizziness—Prednisone—psoriasis	6.87e-05	0.000244	CcSEcCtD
Buspirone—Body temperature increased—Methotrexate—psoriasis	6.87e-05	0.000244	CcSEcCtD
Buspirone—ABCB1—Allograft Rejection—HLA-C—psoriasis	6.84e-05	0.00503	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—IL13—psoriasis	6.8e-05	0.005	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—HCAR2—psoriasis	6.78e-05	0.00499	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—HCAR2—psoriasis	6.67e-05	0.00491	CbGpPWpGaD
Buspirone—HTR1A—G alpha (i) signalling events—CCL20—psoriasis	6.62e-05	0.00487	CbGpPWpGaD
Buspirone—Vomiting—Prednisone—psoriasis	6.61e-05	0.000235	CcSEcCtD
Buspirone—Rash—Prednisone—psoriasis	6.55e-05	0.000233	CcSEcCtD
Buspirone—Dermatitis—Prednisone—psoriasis	6.55e-05	0.000233	CcSEcCtD
Buspirone—Headache—Prednisone—psoriasis	6.51e-05	0.000231	CcSEcCtD
Buspirone—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	6.49e-05	0.00478	CbGpPWpGaD
Buspirone—Hypersensitivity—Methotrexate—psoriasis	6.4e-05	0.000227	CcSEcCtD
Buspirone—HTR2A—SIDS Susceptibility Pathways—IL13—psoriasis	6.27e-05	0.00461	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—IL17A—psoriasis	6.25e-05	0.0046	CbGpPWpGaD
Buspirone—Asthenia—Methotrexate—psoriasis	6.23e-05	0.000221	CcSEcCtD
Buspirone—Nausea—Prednisone—psoriasis	6.17e-05	0.000219	CcSEcCtD
Buspirone—Pruritus—Methotrexate—psoriasis	6.14e-05	0.000218	CcSEcCtD
Buspirone—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	6.04e-05	0.00445	CbGpPWpGaD
Buspirone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.98e-05	0.0044	CbGpPWpGaD
Buspirone—Diarrhoea—Methotrexate—psoriasis	5.94e-05	0.000211	CcSEcCtD
Buspirone—ABCB1—Allograft Rejection—IL12B—psoriasis	5.81e-05	0.00428	CbGpPWpGaD
Buspirone—DRD2—G alpha (i) signalling events—CCL20—psoriasis	5.81e-05	0.00428	CbGpPWpGaD
Buspirone—Dizziness—Methotrexate—psoriasis	5.74e-05	0.000204	CcSEcCtD
Buspirone—ABCB1—Allograft Rejection—HLA-E—psoriasis	5.67e-05	0.00418	CbGpPWpGaD
Buspirone—Vomiting—Methotrexate—psoriasis	5.52e-05	0.000196	CcSEcCtD
Buspirone—Rash—Methotrexate—psoriasis	5.48e-05	0.000195	CcSEcCtD
Buspirone—Dermatitis—Methotrexate—psoriasis	5.47e-05	0.000194	CcSEcCtD
Buspirone—Headache—Methotrexate—psoriasis	5.44e-05	0.000193	CcSEcCtD
Buspirone—HTR2B—GPCR downstream signaling—HCAR2—psoriasis	5.38e-05	0.00396	CbGpPWpGaD
Buspirone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.29e-05	0.00389	CbGpPWpGaD
Buspirone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	5.26e-05	0.00388	CbGpPWpGaD
Buspirone—Nausea—Methotrexate—psoriasis	5.16e-05	0.000183	CcSEcCtD
Buspirone—DRD3—GPCR downstream signaling—HCAR2—psoriasis	5e-05	0.00368	CbGpPWpGaD
Buspirone—CYP3A4—Biological oxidations—CYP2S1—psoriasis	4.95e-05	0.00365	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—CCL20—psoriasis	4.94e-05	0.00364	CbGpPWpGaD
Buspirone—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	4.89e-05	0.0036	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—HCAR2—psoriasis	4.88e-05	0.0036	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	4.7e-05	0.00346	CbGpPWpGaD
Buspirone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	4.62e-05	0.0034	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—CCL20—psoriasis	4.6e-05	0.00339	CbGpPWpGaD
Buspirone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	4.55e-05	0.00335	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—HCAR2—psoriasis	4.54e-05	0.00335	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—IL10—psoriasis	4.54e-05	0.00334	CbGpPWpGaD
Buspirone—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	4.37e-05	0.00322	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—HCAR2—psoriasis	4.36e-05	0.00321	CbGpPWpGaD
Buspirone—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.27e-05	0.00315	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—IL10—psoriasis	4.25e-05	0.00313	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—IL4—psoriasis	4.14e-05	0.00304	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—HLA-B—psoriasis	4.04e-05	0.00298	CbGpPWpGaD
Buspirone—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	4.04e-05	0.00297	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—CCL20—psoriasis	4.01e-05	0.00295	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HCAR2—psoriasis	3.96e-05	0.00292	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—IL10—psoriasis	3.92e-05	0.00289	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—HCAR2—psoriasis	3.83e-05	0.00282	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—HCAR2—psoriasis	3.77e-05	0.00277	CbGpPWpGaD
Buspirone—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	3.76e-05	0.00277	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.75e-05	0.00276	CbGpPWpGaD
Buspirone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.68e-05	0.00271	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—CCL20—psoriasis	3.52e-05	0.00259	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—LEP—psoriasis	3.5e-05	0.00258	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HCAR2—psoriasis	3.48e-05	0.00256	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—CCL20—psoriasis	3.46e-05	0.00255	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	3.42e-05	0.00252	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—HCAR2—psoriasis	3.42e-05	0.00252	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—NOS2—psoriasis	3.26e-05	0.0024	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—PPARG—psoriasis	3.05e-05	0.00224	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—NDUFA5—psoriasis	2.97e-05	0.00218	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HCAR2—psoriasis	2.89e-05	0.00212	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—CCL20—psoriasis	2.79e-05	0.00206	CbGpPWpGaD
Buspirone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2.72e-05	0.002	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HCAR2—psoriasis	2.68e-05	0.00198	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—LEP—psoriasis	2.68e-05	0.00197	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—CCL20—psoriasis	2.6e-05	0.00191	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—CCL20—psoriasis	2.54e-05	0.00187	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CYP2S1—psoriasis	2.52e-05	0.00186	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TAGAP—psoriasis	2.5e-05	0.00184	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—IFNG—psoriasis	2.5e-05	0.00184	CbGpPWpGaD
Buspirone—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.5e-05	0.00184	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—NOS2—psoriasis	2.49e-05	0.00184	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.48e-05	0.00183	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—CCL20—psoriasis	2.36e-05	0.00174	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HCAR2—psoriasis	2.34e-05	0.00172	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—PPARG—psoriasis	2.33e-05	0.00172	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TAGAP—psoriasis	2.33e-05	0.00171	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.32e-05	0.00171	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—JUN—psoriasis	2.31e-05	0.0017	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—CCL20—psoriasis	2.27e-05	0.00167	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.22e-05	0.00163	CbGpPWpGaD
Buspirone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.18e-05	0.0016	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—JUN—psoriasis	2.16e-05	0.00159	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.14e-05	0.00158	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—NDUFA5—psoriasis	2.14e-05	0.00158	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—CCL20—psoriasis	2.06e-05	0.00151	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HCAR2—psoriasis	2.05e-05	0.00151	CbGpPWpGaD
Buspirone—DRD3—G alpha (i) signalling events—CXCL8—psoriasis	2.05e-05	0.00151	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TAGAP—psoriasis	2.03e-05	0.00149	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HCAR2—psoriasis	2.02e-05	0.00149	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.02e-05	0.00148	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—JUN—psoriasis	1.99e-05	0.00147	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—CCL20—psoriasis	1.99e-05	0.00146	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—CCL20—psoriasis	1.96e-05	0.00144	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.92e-05	0.00141	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.91e-05	0.00141	CbGpPWpGaD
Buspirone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	1.9e-05	0.0014	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.89e-05	0.00139	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CYP2S1—psoriasis	1.82e-05	0.00134	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—CCL20—psoriasis	1.81e-05	0.00133	CbGpPWpGaD
Buspirone—HTR1A—G alpha (i) signalling events—CXCL8—psoriasis	1.79e-05	0.00132	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TAGAP—psoriasis	1.78e-05	0.00131	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—CCL20—psoriasis	1.78e-05	0.00131	CbGpPWpGaD
Buspirone—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.75e-05	0.00129	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TAGAP—psoriasis	1.75e-05	0.00129	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.74e-05	0.00128	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—TNF—psoriasis	1.73e-05	0.00127	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—JUN—psoriasis	1.65e-05	0.00122	CbGpPWpGaD
Buspirone—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.63e-05	0.0012	CbGpPWpGaD
Buspirone—ABCB1—Allograft Rejection—TNF—psoriasis	1.62e-05	0.00119	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—NDUFA5—psoriasis	1.62e-05	0.00119	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.61e-05	0.00118	CbGpPWpGaD
Buspirone—DRD2—G alpha (i) signalling events—CXCL8—psoriasis	1.57e-05	0.00116	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NDUFA5—psoriasis	1.52e-05	0.00112	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.5e-05	0.00111	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CCL20—psoriasis	1.5e-05	0.0011	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—TNF—psoriasis	1.49e-05	0.0011	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.43e-05	0.00106	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—TP53—psoriasis	1.43e-05	0.00105	CbGpPWpGaD
Buspirone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.42e-05	0.00105	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CCL20—psoriasis	1.39e-05	0.00103	CbGpPWpGaD
Buspirone—HTR1A—SIDS Susceptibility Pathways—IL6—psoriasis	1.39e-05	0.00103	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CYP2S1—psoriasis	1.38e-05	0.00101	CbGpPWpGaD
Buspirone—HTR2B—GPCR ligand binding—CXCL8—psoriasis	1.33e-05	0.000983	CbGpPWpGaD
Buspirone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.33e-05	0.000979	CbGpPWpGaD
Buspirone—DRD3—Circadian rythm related genes—IL6—psoriasis	1.31e-05	0.000961	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CYP2S1—psoriasis	1.3e-05	0.000954	CbGpPWpGaD
Buspirone—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.25e-05	0.000919	CbGpPWpGaD
Buspirone—DRD3—GPCR ligand binding—CXCL8—psoriasis	1.24e-05	0.000915	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CARM1—psoriasis	1.23e-05	0.000907	CbGpPWpGaD
Buspirone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.23e-05	0.000904	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CCL20—psoriasis	1.22e-05	0.000895	CbGpPWpGaD
Buspirone—HTR2A—SIDS Susceptibility Pathways—IL6—psoriasis	1.2e-05	0.000887	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—TP53—psoriasis	1.09e-05	0.000804	CbGpPWpGaD
Buspirone—HTR1A—GPCR ligand binding—CXCL8—psoriasis	1.08e-05	0.000797	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCL20—psoriasis	1.07e-05	0.000786	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.07e-05	0.000785	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCL20—psoriasis	1.05e-05	0.000773	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.03e-05	0.000756	CbGpPWpGaD
Buspirone—DRD2—Circadian rythm related genes—IL6—psoriasis	9.99e-06	0.000736	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NDUFA5—psoriasis	9.97e-06	0.000734	CbGpPWpGaD
Buspirone—DRD2—GPCR ligand binding—CXCL8—psoriasis	9.5e-06	0.0007	CbGpPWpGaD
Buspirone—HTR2A—GPCR ligand binding—CXCL8—psoriasis	9.35e-06	0.000689	CbGpPWpGaD
Buspirone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	9.32e-06	0.000686	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	9.32e-06	0.000686	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CARM1—psoriasis	8.9e-06	0.000655	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP2S1—psoriasis	8.47e-06	0.000624	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SOCS1—psoriasis	8.25e-06	0.000608	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	7.98e-06	0.000588	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—TYK2—psoriasis	7.87e-06	0.000579	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SOCS1—psoriasis	7.68e-06	0.000565	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—CAT—psoriasis	7.57e-06	0.000558	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—CXCL8—psoriasis	7.54e-06	0.000555	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—TYK2—psoriasis	7.32e-06	0.000539	CbGpPWpGaD
Buspirone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.04e-06	0.000518	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—CXCL8—psoriasis	7.02e-06	0.000517	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—CXCL8—psoriasis	6.85e-06	0.000504	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CARM1—psoriasis	6.72e-06	0.000495	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SOCS1—psoriasis	6.69e-06	0.000493	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—TYK2—psoriasis	6.38e-06	0.00047	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—CXCL8—psoriasis	6.37e-06	0.000469	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CARM1—psoriasis	6.33e-06	0.000466	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	6.12e-06	0.00045	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—APOE—psoriasis	6.09e-06	0.000448	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—LEP—psoriasis	6.09e-06	0.000448	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—APOE—psoriasis	5.88e-06	0.000433	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SOCS1—psoriasis	5.88e-06	0.000433	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SOCS1—psoriasis	5.78e-06	0.000426	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NFKBIA—psoriasis	5.67e-06	0.000418	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—LEP—psoriasis	5.67e-06	0.000417	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—APOE—psoriasis	5.67e-06	0.000417	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—TYK2—psoriasis	5.6e-06	0.000412	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—CXCL8—psoriasis	5.56e-06	0.000409	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—TYK2—psoriasis	5.51e-06	0.000406	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CAT—psoriasis	5.47e-06	0.000403	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—CXCL8—psoriasis	5.37e-06	0.000395	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	5.29e-06	0.000389	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NFKBIA—psoriasis	5.28e-06	0.000389	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PPARG—psoriasis	5.13e-06	0.000377	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—APOE—psoriasis	4.94e-06	0.000364	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—LEP—psoriasis	4.94e-06	0.000364	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—CXCL8—psoriasis	4.88e-06	0.000359	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—CXCL8—psoriasis	4.8e-06	0.000353	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TYK2—psoriasis	4.65e-06	0.000342	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NFKBIA—psoriasis	4.6e-06	0.000339	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—LEP—psoriasis	4.34e-06	0.000319	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—APOE—psoriasis	4.34e-06	0.000319	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TYK2—psoriasis	4.32e-06	0.000318	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—APOE—psoriasis	4.27e-06	0.000314	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—LEP—psoriasis	4.27e-06	0.000314	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—APOE—psoriasis	4.25e-06	0.000313	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CARM1—psoriasis	4.14e-06	0.000305	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CAT—psoriasis	4.13e-06	0.000304	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CXCL8—psoriasis	4.05e-06	0.000298	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NFKBIA—psoriasis	4.04e-06	0.000297	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NFKBIA—psoriasis	3.98e-06	0.000293	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CAT—psoriasis	3.89e-06	0.000287	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—IL6—psoriasis	3.85e-06	0.000283	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TYK2—psoriasis	3.77e-06	0.000278	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CXCL8—psoriasis	3.77e-06	0.000277	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—JUN—psoriasis	3.76e-06	0.000277	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PPARG—psoriasis	3.71e-06	0.000273	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NFKB1—psoriasis	3.62e-06	0.000267	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—IL6—psoriasis	3.58e-06	0.000264	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—JUN—psoriasis	3.5e-06	0.000258	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NFKB1—psoriasis	3.37e-06	0.000248	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TYK2—psoriasis	3.31e-06	0.000244	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—VEGFA—psoriasis	3.29e-06	0.000242	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CXCL8—psoriasis	3.28e-06	0.000242	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TYK2—psoriasis	3.26e-06	0.00024	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—STAT3—psoriasis	3.25e-06	0.00024	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—APOE—psoriasis	3.21e-06	0.000236	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—IL6—psoriasis	3.12e-06	0.00023	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—VEGFA—psoriasis	3.06e-06	0.000225	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—JUN—psoriasis	3.05e-06	0.000225	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—STAT3—psoriasis	3.03e-06	0.000223	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—APOE—psoriasis	3.02e-06	0.000223	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NFKB1—psoriasis	2.94e-06	0.000216	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CXCL8—psoriasis	2.88e-06	0.000212	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CXCL8—psoriasis	2.84e-06	0.000209	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PPARG—psoriasis	2.8e-06	0.000206	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—IL6—psoriasis	2.74e-06	0.000202	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—IL6—psoriasis	2.7e-06	0.000198	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—JUN—psoriasis	2.68e-06	0.000197	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—VEGFA—psoriasis	2.67e-06	0.000196	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—STAT3—psoriasis	2.64e-06	0.000194	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—JUN—psoriasis	2.64e-06	0.000194	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PPARG—psoriasis	2.63e-06	0.000194	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NFKB1—psoriasis	2.58e-06	0.00019	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CAT—psoriasis	2.55e-06	0.000187	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NFKB1—psoriasis	2.54e-06	0.000187	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TP53—psoriasis	2.48e-06	0.000183	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—VEGFA—psoriasis	2.34e-06	0.000172	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—STAT3—psoriasis	2.32e-06	0.000171	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TP53—psoriasis	2.31e-06	0.00017	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—VEGFA—psoriasis	2.3e-06	0.00017	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—STAT3—psoriasis	2.28e-06	0.000168	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL6—psoriasis	2.27e-06	0.000167	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL6—psoriasis	2.12e-06	0.000156	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TP53—psoriasis	2.01e-06	0.000148	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—APOE—psoriasis	1.98e-06	0.000146	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL6—psoriasis	1.84e-06	0.000136	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TP53—psoriasis	1.77e-06	0.00013	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TP53—psoriasis	1.74e-06	0.000128	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PPARG—psoriasis	1.72e-06	0.000127	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL6—psoriasis	1.62e-06	0.000119	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL6—psoriasis	1.59e-06	0.000117	CbGpPWpGaD
